Bipolar Affective Disorder. Clinical Aspects and Comorbidity-Reference-Cited by-同舟云学术

Bipolar Affective Disorder. Clinical Aspects and Comorbidity

Published:2020 Issue:1 Volume:28 Page:166-179
ISSN:2075-3470
Container-title:Консультативная психология и психотерапия
language:
Short-container-title:

Author:

Dovzhenko T.V.¹,Tsarenko D.M.²,Yudeeva T.Yu.³

Affiliation:

1. Moscow Research Institute of Psychiatry - Federal Budgetary Institution "V. Serbsky National Medical Research Centre for Psychiatry and Narcology" of the Ministry of Health of Russia

2. Moscow Research Institute of Psychiatry— Branch of The Serbsky Federal Medical Research Center for Psychiatry and Narcology

3. Moscow Research Institute of Psychiatry — Branch of The Serbsky Federal Medical Research Center for Psychiatry and Narcology

Abstract

The review of the literature describes the clinical features of bipolar affective disorder (BAD). Difficulties in diagnosing BAD due to the complex clinical picture that cause untimely diagnosis and the formation of an unfavorable course of the disease are examined in detail. The data on mental disorders it is necessary to differentiate BAD from are presented. The characteristics of the course of BAD are described in detail, including unfavorable forms and mixed bipolar conditions, which are difficult to diagnose and treat, and present a negative prognostic factor. The data on the deterioration of the cognitive abilities of patients with an increase in the number of episodes of BAD, which can occur even during euthymy, are considered. Particular attention is paid to the consideration of forms of mental and somatic pathology, comorbid BAD associated with a decrease in the quality of life, poor prognosis, increased disability, and premature mortality.

Publisher

Federal State-Financed Educational Institution of Higher Education Moscow State University of Psychology and Education

Subject

Clinical Psychology,Health (social science),Developmental and Educational Psychology

Link

https://psyjournals.ru/files/112640/cpp_2020_n1_Dovzhenko_Tsarenko_Yudeeva.pdf

Reference43 articles.

1. Kuzavkova M.V., Kostyukova E.G., Mosolov S.N. Kliniko-farmakokineticheskii prognoz effektivnosti antikonvulâsantov, normotimikov i solei litiya pri vtorichnoi profilaktike shizoaffektivnogo i affektivnogo psikhozov. Novye dostizheniya v terapii psikhicheskikh zabolevanii [Clinical and pharmacokinetic prognosis of the effectiveness of anticonvulsants, normotimics and lithium salts in the secondary prevention of schizoaffective and affective psychoses]. In Mosolov S.N. (ed.). Novye dostizheniya v terapii psikhicheskikh zabolevanii [ New findings in metal disorders therapy]. Moscow: âBINOM. Laboratoriya znaniiâ Publ., 2002, pp. 356â372.

2. Mosolov S.N., Kostyukova E.G., Kuzavkova M.V. Bipolyarnoe affektivnoe rasstroistvo: diagnostika i terapiya [Bipolar Affective Disorder: Diagnosis and Therapy]. Moscow: MEDpress-inform, 2008. 384 p.

3. Allilaire J.F. Diagnosis of Bipolar Disorder and Rationale of Early Treatment. Bulletin de lâAcademie nationale de medecine, 2010. Vol. 194 (9), pp. 1695â1703.

4. Altamura A.C., DellâOsso B., Berlin H.A., et al. Duration of untreated illness and suicide in bipolar disorder: a naturalistic study. European Archives of Psychiatry and Clinical Neuroscience, 2010. Vol. 260 (5), pp. 385â391.

5. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision) [Elektronnyi resurs]. 2002 Available at: https:// psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/ bipolar.pdf (Accessed 10.11.2019). // American Journal of Psychiatry. 2002. Vol. 159. â 4. P. 1â50.